Effects of Rheum tanguticum polysaccharide on TNBS-induced colitis and CD4+T cells in rats

World Journal of Gastroenterology

Volumn 9, Issue 10, 2003, Pages 2284-2288

  Liu, Li ^a   Wang, Zhi Peng ^a   Xu, Chang Tai ^a   Pan, Bo Rong ^b   Mei, Qi Bing ^a   Long, Yin ^a   Liu, Jia Yin ^a   Zhou, Si Yuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MYELOPEROXIDASE; PLANT EXTRACT; RHEUM TANGUTICUM POLYSACCHARIDE; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CELL ISOLATION; CELL LEVEL; CHROMATOGRAPHY; COLITIS; COLON MUCOSA; COLON ULCER; CONTROLLED STUDY; DIARRHEA; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MALE; MEDICINAL PLANT; MESENTERY LYMPH NODE; MORTALITY; NONHUMAN; ORGAN WEIGHT; PROTECTION; PROTEIN EXPRESSION; RAT; RHEUM TANGUTICUM; SPLEEN; T LYMPHOCYTE; THYMUS ATROPHY; WEIGHT REDUCTION; WESTERN BLOTTING;

EID: 0142244381     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i10.2284     Document Type: Article

References (35)

1. Alstead E. Fertility and pregnancy in inflammatory bowel disease. World J Gastroenterol 2001; 7: 455-459
2. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol 2001; 7: 175-184
3. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20: 495-549
4. Yoshida M, Shirai Y, Watanabe T, Yamori M, Iwakura Y, Chiba T, Kita T, Wakatsuki Y. Differential localization of colitogenic Th1 and Th2 cells monospecific to a microflora-associated antigen in mice. Gastroenterology 2002; 123: 1949-1961
5. Elson CO, Cong Y. Understanding immune-microbial homeostasis in intestine. Immunol Res 2002; 26: 87-94
6. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998; 187: 855-864
7. Monteleone I, Vavassori P, Biancone L, Monteleone G, Pallone F. Immunoregulation in the gut: Success and failures in human disease. Gut 2002; 50(Suppl 3): III60-64
8. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000; 165: 4848-4853
9. Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 2000; 119: 724-733
10. Mizoguchi A, Mizoguchi E, Saubermann LJ, Higaki K, Blumberg RS, Bhan AK. Limited CD4 T-cell diversity associated with colitis in T-cell receptor alpha mutant mice requires a T helper 2 environment. Gastroenterology 2000; 119: 983-995
11. + T regulatory cells from the colonic lamina propria of normal mice inhibit proliferation of enterobacteria-reactive, disease-inducing Th1-cells from scid mice with colitis. Clin Exp Immunol 2003; 131: 34-40
12. Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002; 122: 1592-1608
13. Van Montfrans C, Rodriguez Pena MS, Pronk I, Ten Kate FJ, Te Velde AA, Van Deventer SJ. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 2002; 123: 1865-1876
14. Singh B, Read S, Asseman C, Malstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200
15. Rachmilewitz D, Karmeli F, Takabayashi K, Hayashi T, Leider-Trejo L, Lee J, Leoni LM, Raz E. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002; 122: 1428-1441
16. Xu CT, Pan BR. Current medical therapy for ulcerative colitis. World J Gastroenterol 1999; 5: 64-72
17. Jani N, Regueiro MD. Medical therapy for ulcerative colitis. Gastroenterol Clin North Am 2002; 31: 147-166
18. Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002; 8: 158-161
19. Salupere R. Inflammatory bowel disease in Estonia: A prospective epidemiologic study 1993-1998. World J Gastroenterol 2001; 7: 387-388
20. Wu HG, Zhou LB, Shi DR, Liu SM, Liu HR, Zhang BM, Chen HP, Zhang LS. Morphological study on colonic ulcerative colitis treated by moxibustion. World J Gastroenterol 2000; 6: 861-865
21. Liu L, Li BL, Mei QB. Effects of tanguticum Maxim polysaccharide on acute liver injury of mice. Disi Junyi Daxue Xuebao 1999; 20: 549-551
22. Liu L, Mei QB, Zhou SY, Li BL. Effects of tanguticum Maxim polysaccharide on antioxidation of mice. Disi Junyi Daxue Xuebao 2001; 22: 530-533
23. Michell NP, Lalor P, Langman MJ. Heparin therapy for ulcerative colitis? Effects and mechanisms. Eur J Gastroenterol Hepatol 2001; 13: 449-456
24. Cui HF, Jiang XL. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterology 1999; 5: 448-450
25. Strickland FM. Immune regulation by polysaccharide: Implications for skin cancer. J Photochem Photobiol B 2001; 63: 132-140
26. Qiu Z, Jones K, Wylie M, Jia Q, Orndorff S. Modified Aloe barbadensis polysaccharide with immunoregulatory activity. Planta Med 2000; 66: 152-156
27. Cho CH, Mei QB, Shang P, Lee SS, So HL, Guo X, Li Y. Study of the gastrointestinal protective effects of polysaccharides from Angelica sinensis in rats. Planta Med 2000; 66: 348-351
28. Zheng L, Gao ZQ, Wang SX. A chronic ulcerative colitis model in rats. World J Gastroenterol 2000; 6: 150-152
29. Gomez-Flores R, Calderon CL, Scheibel LW, Tamez-Guerra P, Rodriguez-Padilla C, Tamez-Guerra R, Weber RJ. Immunoenhancing properties of Plantago major leaf extract. Phytother Res 2000; 14: 617-622
30. Han SB, Park SH, Lee KH, Lee CW, Lee SH, Kim HC, Kim YS, Lee HS, Kim HM. Polysaccharide isolated from the radix of Platycodon grandiflorum selectively activates B cells and macrophages but not T cells. Int Immunopharmacol 2001; 1: 1969-1978
31. Strober W, Fuss IJ, Ehrhardt RO, Neurath M, Boirivant M, Ludviksson BR. Mucosal immunoregulation and inflammatory bowel disease: New insights from murine models of inflammation. Scand J Immunol 1998; 48: 453-458
32. (+) T cells. Gut 2002; 50: 299-306
33. (+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab Invest 2001; 81: 1339-1349
34. (+) regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, leishmania major infection, and colitis in mice. J Immunol 2003; 170: 394-399
35. (+) T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness. J Immunol 1999; 162: 3702-3710